1 | INSM | Insmed Incorporated | 4.76% |
2 | EXEL | Exelixis, Inc. | 4.66% |
3 | COR | Cencora, Inc. | 4.41% |
4 | BBIO | BridgeBio Pharma, Inc. | 4.16% |
5 | LLY | Eli Lilly and Company | 3.88% |
6 | BSX | Boston Scientific Corporation | 3.83% |
7 | GH | Guardant Health, Inc. | 3.76% |
8 | RMD | ResMed Inc. | 3.66% |
9 | TGTX | TG Therapeutics, Inc. | 3.47% |
10 | MASS | 908 Devices Inc. | 3.47% |
11 | PTGX | Protagonist Therapeutics, Inc. | 3.33% |
12 | AXSM | Axsome Therapeutics, Inc. | 3.15% |
13 | ABBV | AbbVie Inc. | 3.07% |
14 | MMSI | Merit Medical Systems, Inc. | 2.93% |
15 | OCUL | Ocular Therapeutix, Inc. | 2.92% |
16 | KRYS | Krystal Biotech, Inc. | 2.86% |
17 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.82% |
18 | ALHC | Alignment Healthcare, Inc. | 2.81% |
19 | MASI | Masimo Corporation | 2.60% |
20 | QURE | uniQure N.V. | 2.59% |
21 | PTCT | PTC Therapeutics, Inc. | 2.57% |
22 | AMRX | Amneal Pharmaceuticals, Inc. | 2.52% |
23 | ARQT | Arcutis Biotherapeutics, Inc. | 2.43% |
24 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.39% |
25 | TRVI | Trevi Therapeutics, Inc. | 2.33% |
View PTH holdings |